megestrol acetate

Preferred Label : megestrol acetate;

MeSH definition : Megestrol acetate is a progestogen with actions and uses similar to those of the progestogens in general. It also has anti-androgenic properties. It is given by mouth in the palliative treatment or as an adjunct to other therapy in endometrial carcinoma and in breast cancer. Megestrol acetate has been approved to treat anorexia and cachexia. (From Reynolds JEF(Ed): Martindale: The Extra Pharmacopoeia (electronic version). Micromedex, Inc, Englewood, CO, 1995);

MeSH synonym : acetate, megestrol;

CISMeF synonym : Nu-Pharm brand of megestrol acetate; nu pharm brand of megestrol acetate; apotex brand of megestrol acetate; squibb brand of megestrol acetate; Bristol-Myers squibb brand of megestrol acetate; bristol myers squibb brand of megestrol acetate; madaus brand of megestrol acetate; linson pharma brand of megestrol acetate; Bristol-Myers brand of megestrol acetate; bristol myers brand of megestrol acetate; prasfarma brand of megestrol acetate; lemery brand of megestrol acetate;

MeSH hyponym : megefren; maygace; borea; megace; Apo-Megestrol; mestrel; Lin-Megestrol; Nu-Megestrol; Lin Megestrol; LinMegestrol; Megostat; Megestat; Nu Megestrol; NuMegestrol; Apo Megestrol; ApoMegestrol;

MeSH CAS label : Pregna-4,6-diene-3,20-dione, 17-(acetyloxy)-6-methyl-;

MeSH Related Number : 51154-23-5 (Megestrol acetate);

Registry Number MeSH : 51154-23-5;

Wikipedia link : https://en.wikipedia.org/wiki/Maygace;

Is substance : O;

UNII : TJ2M0FR8ES;

InChIKey : RQZAXGRLVPAYTJ-GQFGMJRRSA-N;

Details

Origin ID

D019290;

UMLS CUI

C0065879;

ATC code(s)
- megestrol [ATC Code]
Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analogs and derivatives [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Automatic exact mappings (from CISMeF team)
- Megestrol acetate preparation (product) [Inactive SNOMED CT concept]
CISMeF manual mappings
- Megestrol acetate (substance) [SNOMED CT concept]
Pharmacological action(s)
- antineoplastic agents, hormonal [MeSH Descriptor]
- appetite stimulants [MeSH Descriptor]
Record concept(s)
- Apo-Megestrol [MeSH concept]
- Lin-Megestrol [MeSH concept]
- Nu-Megestrol [MeSH concept]
- borea [MeSH concept]
- maygace [MeSH concept]
- megace [MeSH concept]
- megefren [MeSH concept]
- megestrol acetate [MeSH concept]
- mestrel [MeSH concept]
Related MeSH Supplementary Concept(s)
- PAV-M protocol [MeSH Supplementary Concept]
- cymegesolate [MeSH Supplementary Concept]
- me-quingestanol [MeSH Supplementary Concept]
- oraconal [MeSH Supplementary Concept]
Semantic type(s)
- Hormone [UMLS semantic type]
- Organic Chemical [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients